Bio-Techne (TECH) free cash flow

Free cash flow · fiscal 2026
$263.22M

Bio-Techne (TECH) generated free cash flow of $263.22M in fiscal 2026 (the year ended June 30, 2026). That is 2.6% higher than the $256.55M of fiscal 2025. Figures as of 18 Nov 2026, 11:40 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2026
$263.22M
Change on fiscal 2025
+2.6%
Growth, 5 years
−3.1% a year
Growth, 10 years
+7.5% a year
Highest on record
$307.86Mfiscal 2021
Lowest on record
$101.11Mfiscal 2013
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Techne free cash flow, in more detail

Over the five fiscal years to 2026 free cash flow shrank at a compound 3.1% a year; over ten years the rate was 7.5% a year. Across the 18 fiscal years on record (2009–2026), the highest was $307.86M in fiscal 2021 and the lowest $101.11M in fiscal 2013.

History · 18 fiscal years

Free cash flow by fiscal year

Bio-Techne free cash flow, year by year

Bio-Techne (TECH) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2026$263.22M 2.6% up
2025$256.55M 8.7% up
2024$236.10M 9.2% up
2023$216.15M 22.9% down
2022$280.36M 8.9% down
2021$307.86M 100.6% up
2020$153.47M 1.8% down
2019$156.21M 4.5% up
2018$149.43M 16.3% up
2017$128.54M 1.0% up
2016$127.26M 6.5% up
2015$119.45M 2.8% down
2014$122.94M 21.6% up
2013$101.11M 16.3% down
2012$120.73M 2.3% down
2011$123.56M 15.9% up
2010$106.62M 1.8% up
2009$104.77M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Bio-Techne and comparable companies
CompanyFree cash flowFiscal year
DaVita DVA$1.31B2025
Halozyme Therapeutics HALO$356.82M2025
Universal Health Services UHS$824.55M2025
Bio-Techne TECH$263.22M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TECH

Bio-Techne, figure by figure

Bio-Techne (TECH) overview: price, valuation and scorecardAll health care companies by market value

Bio-Techne free cash flow: questions and answers

What is Bio-Techne's free cash flow?

Bio-Techne (TECH) generated free cash flow of $263.22M in fiscal 2026 (the year ended June 30, 2026). That is 2.6% higher than the $256.55M of fiscal 2025.

What is the growth rate of Bio-Techne's free cash flow?

Over the five fiscal years to 2026 free cash flow shrank at a compound 3.1% a year; over ten years the rate was 7.5% a year.

What are the highest and lowest free cash flow figures on record for Bio-Techne?

Across the 18 fiscal years on record (2009–2026), the highest was $307.86M in fiscal 2021 and the lowest $101.11M in fiscal 2013.

How is Bio-Techne's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Bio-Techne it is on record here for 18 fiscal years, 2009 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Techne (TECH) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/TECH/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.